Differential Regulation of Matrix-Metalloproteinases and Their Tissue Inhibitors in Patients with Aneurysmal Subarachnoid Hemorrhage

Abstract

BackgroundMatrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are involved in vascular remodeling, (neuro)inflammation, blood-brain barrier breakdown and neuronal apoptosis. Proinflammatory mechanisms are suggested to play an important role during early brain injury and cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH). This study aimed to analyze MMP-3, MMP-9, TIMP-1 and TIMP-3 in patients with SAH and their respective association with cerebral vasospasm (CVS).MethodsBlood samples were collected in 20 SAH patients on days 1 to 7, 9, 11, 13 and 15 and 20 healthy age and gender matched volunteers. Serum MMPs and TIMPs were analyzed using enzyme-linked immunosorbent assay. Doppler sonographic CVS was defined as a mean blood flow velocity above 120 cm/sec in the middle cerebral artery. When discharged from hospital and at 6 month follow-up neurological outcome was evaluated using the Glasgow Outcome Score and the modified Rankin Scale.ResultsMMP-9 was higher in SAH patients compared to healthy controls (p<0.001). Patients with CVS (n = 11) had elevated MMP-9 serum levels compared to patients without CVS (n = 9, p<0.05). Higher MMP-9 was observed in the presence of cerebral ischemia associated with cerebral vasospasm (p<0.05). TIMP-1 was increased in patients with SAH on day 4 (p<0.05). There was an imbalance of the MMP-9/TIMP-1 ratio in favor of MMP-9 in SAH patients, in particular those with CVS (p<0.001). MMP-3 and TIMP-3 were significantly lower in SAH patients throughout day 4 and day 7, respectively (p<0.05). We did not find an association between MMP-, TIMP levels and neurological outcome after 6 months.ConclusionsMMP-3 and -9 are differentially regulated in SAH patients with both enzymes showing peak levels correlating with the development of CVS. The inhibitors TIMP-1 and -3 were low during the acute phase after SAH and increased later on which might suggest a preponderance of pro-inflammatory mechanisms.

Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase‐9 inhibition

“…Four other studies examined the relationship between MMP‐9 levels and radiographic vasospasm in SAH patients. Of these, three reported an association between higher levels of blood MMP‐9 and cerebral vasospasm, while the other reported a nonsignificant trend toward higher CSF MMP‐9 levels and cerebral vasospasm. Taken together, these preclinical and clinical studies suggest, but do not definitively establish, a role for MMP‐9 in the pathophysiology of vasospasm and DCI after SAH.…”

Opposing Effects of NGF and proNGF on HIV Induced Macrophage Activation

“…However, the increased secretion of both MMP-9 and its endogenous inhibitor TIMP-1 indicated that the hMDM secrete potentially deleterious and protective proteins at the same time in an effort to maintain tissue homeostasis. The balance between MMP-9 and TIMP-1 has been seen in other brain injury models including ALS (Louboutin et al 2011;Tsai et al 2011;Fischer et al 2013;Wu et al 2015) and may be a crucial factor in the regulation of tissue damage. Evidence for deleterious effects when the balance is changed was seen when proNGF was added to HIV.…”

Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage

“…Fischer et al evaluated blood samples in 20 patients with aSAH and showed that MMP‐9 was higher in aSAH patients compared to healthy controls ( P < .001) and an increase in MMP correlated with occurrence of vasospasm ( P < .05).…”